China Resources Pharmaceutical Group Ltd. (01093.HK)SYS 6036 Injection approved for clinical trials in China.

Zhixin Finance News APP reports that Sihuan Pharmaceutical Group (01093.HK) has announced that its SYS 6036 injection has been approved by the National Medical Products Administration of the People's Republic of China and can now conduct clinical trials in China.